These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28423673)

  • 1. Ceruloplasmin as a prognostic marker in patients with bile duct cancer.
    Han IW; Jang JY; Kwon W; Park T; Kim Y; Lee KB; Kim SW
    Oncotarget; 2017 Apr; 8(17):29028-29037. PubMed ID: 28423673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic studies on perineural invasion of bile duct carcinoma.
    Bhuiya MR; Nimura Y; Kamiya J; Kondo S; Fukata S; Hayakawa N; Shionoya S
    Ann Surg; 1992 Apr; 215(4):344-9. PubMed ID: 1558415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasion Depth Measured in Millimeters is a Predictor of Survival in Patients with Distal Bile Duct Cancer: Decision Tree Approach.
    Min KW; Kim DH; Son BK; Kim EK; Ahn SB; Kim SH; Jo YJ; Park YS; Seo J; Oh YH; Oh S; Kim HY; Kwon MJ; Min SK; Park HR; Choe JY; Jeon JY; Ha HI; Lee JW
    World J Surg; 2017 Jan; 41(1):232-240. PubMed ID: 27549598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma.
    Kijima H; Wu Y; Yosizawa T; Suzuki T; Tsugeno Y; Haga T; Seino H; Morohashi S; Hakamada K
    J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):453-8. PubMed ID: 24591403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphology, TNM staging and survival with Pancreatico-duodenectomy specimens received at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan.
    Qureshi A; Hassan U; Azam M
    Asian Pac J Cancer Prev; 2011; 12(4):953-6. PubMed ID: 21790232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Klatskin tumor: long-term survival following surgery].
    Juntermanns B; Fingas CD; Sotiropoulos GC; Jaradat D; Dechêne A; Reis H; Kasper S; Paul A; Kaiser GM
    Chirurg; 2016 Jun; 87(6):514-9. PubMed ID: 27090415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
    Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
    J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural cell adhesion molecule (NCAM) and perineural invasion in bile duct cancer.
    Seki H; Tanaka J; Sato Y; Kato Y; Umezawa A; Koyama K
    J Surg Oncol; 1993 Jun; 53(2):78-83. PubMed ID: 8501910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas.
    Riener MO; Fritzsche FR; Clavien PA; Pestalozzi BC; Probst-Hensch N; Jochum W; Kristiansen G
    Hum Pathol; 2009 Oct; 40(10):1377-83. PubMed ID: 19467694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histological appearance of carcinoma of the upper bile duct and the mode of its spread].
    Ouchi K; Suzuki M; Matsuno S; Sato T
    Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):845-51. PubMed ID: 3670270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
    Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
    Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of pancreatic invasion in T1-stage distal bile duct cancer and prognostic factors associated with long-term survival: A multicenter study.
    Jeon YW; Kang CM; Yoon YS; Kwon W; Han SS; Park Y; Kwak BJ; Lee W; Song KB; Lee JH; Kim SC; Shin SH; Hwang DW
    J Hepatobiliary Pancreat Sci; 2024 Sep; 31(9):658-670. PubMed ID: 39054662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic determinants in extrahepatic bile duct cancer.
    Kurosaki I; Tsukada K; Watanabe H; Hatakeyama K
    Hepatogastroenterology; 1998; 45(22):905-9. PubMed ID: 9755978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma.
    Oguro S; Esaki M; Kishi Y; Nara S; Shimada K; Ojima H; Kosuge T
    Ann Surg Oncol; 2015; 22(6):1915-24. PubMed ID: 25404474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of the definition of early extrahepatic bile duct cancer through the prognosis analysis who had received curative resection].
    Kim HJ; Bang S; Park SW; Song SY; Kim KS; Lee WJ; Chung JB
    Korean J Gastroenterol; 2007 Aug; 50(2):101-7. PubMed ID: 17928753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve Growth Factor Expression Is Not Associated with Perineural Invasion in Extrahepatic Cholangiocarcinoma.
    Urabe K; Murakami Y; Kondo N; Uemura K; Hashimoto Y; Nakagawa N; Sasaki H; Hiyama E; Takahashi S; Sueda T
    Dig Dis Sci; 2016 Mar; 61(3):774-84. PubMed ID: 26547754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.